This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.
patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost genericmedicines to the marketplace, according to a STAT analysis. Amid debate over potential abuse of the U.S.
In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a genericmedicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.
As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used genericmedicine for my blood pressure without a problem, so I hoped for the best with this switch.
Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost genericmedicines in the marketplace.
Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost genericmedicines in the marketplace.
Amid ongoing concern over the quality of medicines made in India, a major supplier of genericmedicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.
In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost genericmedicines.
A handful of the largest purveyors of genericmedicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.
A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive genericmedicines are unavailable, prices vary widely, and savings can be modest.
A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable genericmedicines in poor countries around the world.
The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost genericmedicines. Continue to STAT+ to read the full story…
A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable genericmedicines in poor countries around the world. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.
But it’s a genericmedicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. There’s just one problem: PBMs don’t have anything to do with that discrepancy. The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs.
At the initiative of Prime Minister Narendra Modi, March 7 is celebrated every year as Jan Aushadhi Diwas to enhance awareness about the scheme and promote genericmedicines. Under this scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened to provide genericmedicines.
The review comes in response to an inspection of Synapse facilities by Spanish regulators, who raised “serious concerns about the validity and reliability” of clinical trial data generated by the company.
The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of genericmedicines
The world is increasingly looking towards India, not just for our contributions to genericmedicines, but for our growing leadership in advanced areas like biologics, medical devices, and digital health.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.
The Indian pharmaceutical sector is loaded with talent and has made great strides in genericmedicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries. A strong pharmaceutical ecosystem relies heavily on research and development (R&D).
George examines the economic impact of generic pharmaceuticals on the U.S. He argues that the generics industry provides safe, effective, and affordable medicines for many Americans. Today’s guest post comes from George Keefe, Senior Vice President of External Affairs and Public Policy at Teva Pharmaceuticals.
Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its genericmedicines industry.
Zena Health plans to strengthen its reach and democratise healthcare in Eastern India Zeno Health, omni channel platform for quality and affordable genericmedicines has announced its acquisition of Kolkata-based startup Tablt Pharmacy.
Goldman Sachs Asset Management, to acquire a majority stake in Synthon International Holdings BV, a company engaged in developing, manufacturing, and out-licensing complex genericmedicines, for a consideration of approximately $2.1 billion; AlpInvest Partners B.V. and Sixth Street Specialty Lending, investing $945.6 million.
The big blow to Sunovion, he said, was the loss of patent protection for Latuda, its best-selling schizophrenia drug, which led to competition from cheaper genericmedicines. Janoschek, 56, had worked for Sunovion and a predecessor firm for 22 years and lost his job in March in a restructuring that shed hundreds of workers.
Britain is pushing for patent changes that could increase the cost of Indian generic drugs, diverting more of the NHS budget to big pharma India is known as the “ pharmacy of the world ”, supplying vital genericmedicines at low prices to health services including the NHS.
“Now more than ever, it is our responsibility as a sector to ensure affordable access to healthcare and enable the future longevity of medicine development and supply.”. The genericsmedicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines.
-Walk-In Interview for Quality Control On 1st Feb’ 2023 Job Description Felix Generics Pvt. is a pharmaceutical generics business Company. HPRA Approved (April 2021) facility for veterinary genericmedicines. Parent entity based in Ireland. Manufacturing facility based at SEZ Pithampur , Indore.
We are committed to maintaining strict adherence to the highest quality standards and to ensuring delivery of safe and effective genericmedicines to our patients in the US and around the world.” ” The post Indoco receives EIR for its manufacturing facility in Goa (Plant I) appeared first on Express Pharma.
Speaking for most doctors, the Indian Medical Association (IMA) compared the National Medical Commission’s (NMC) push towards promotion of generics as “running trains without tracks’’, reasoning that not all genericmedicines are of the same quality as their branded counterparts.
Indian Medical Association says that testing is substandard in the manufacture of genericmedicines with ‘no guarantee of quality’ Indian doctors have been told they can no longer prescribe branded drugs for their patients, provoking vehement protest from the Indian Medical Association [IMA].
Novartis revealed today that it may consider divesting its genericmedicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines.
Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for genericmedicines will be a significant factor for growth.
Additionally, approval was recommended two genericmedicines: Enzalutamide Viatris (enzalutamide) to treat prostate cancer, and Nilotinib Accord (nilotinib) was also recommended to treat Philadelphia chromosome positive chronic myelogenous leukaemia.
The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for medicine) Mankind Pharma has introduced 120 DMF (Drug Master File) Quality Medicines in the Indian market. This initiative aims to ensure universal access to medicines of international calibre.
For Sandoz, the acquisition gives it a technology platform in an area of the genericmedicines market with a relatively high barrier to entry, as developing inhaled medicines poses “comparatively high technical complexity,” according to Sandoz chief executive Richard Saynor.
” It also sees continued growth in cardiovascular and venous diseases, as well as in genericmedicines, and says its new visual identity (see above) reflects its “uniqueness” as an “independent group, governed by a foundation, committed to therapeutic progress to serve patient needs.”
.” Dr Chandrashekar Ranga, Joint Drugs Controller, India, will discuss the obstacles regulators face in the digital era; Dr Stewart Geary, Global Safety Officer, Eisai and a Fellow of DIA, will provide updates on behalf of the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII on Benefit-Risk Balance for Medicinal (..)
Over the same period, total gross expenditures on brand and genericmedicines nearly doubled – from $268 billion to $517 billion, according to the report.
Meanwhile, Sandoz would leverage its strong brand and sustain its leading global position by continuing to invest in the key strategic areas of Biosimilars, Antibiotics and GenericMedicines. Working to deliver on its vision of access to patients. Additional transaction details.
Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding genericmedicines, beckons for clarity.
The company offers genericmedicines and biosimilars through Sandoz. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others.
-Walk-In Interview Walk-In Interview for Freshers & Experienced in Engineering/ QA/ QC On 20th Feb’ 2023 Job Description Felix Generics Pvt. is a pharmaceutical generics business Company. HPRA Approved (April 2021) facility for veterinary genericmedicines. Parent entity based in Ireland.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content